Advocacy at a Glance Guest User 3/12/16 Advocacy at a Glance Guest User 3/12/16 FDA to Apply Lean Management Tools to Handling of Combination Products and more Read More Analysis and Commentary Guest User 3/4/16 Analysis and Commentary Guest User 3/4/16 Califf Debuts on Capitol Hill with Two Priorities Read More Advocacy at a Glance Guest User 3/4/16 Advocacy at a Glance Guest User 3/4/16 National Biomedical Research Act Introduced Read More Analysis and Commentary Guest User 2/27/16 Analysis and Commentary Guest User 2/27/16 "Everything is a high priority" for the FDA today Read More Advocacy at a Glance Guest User 2/27/16 Advocacy at a Glance Guest User 2/27/16 Details on FDA’s Request for FY 17 FSMA Appropriations and more Read More Analysis and Commentary Guest User 2/19/16 Analysis and Commentary Guest User 2/19/16 Alliance Seeks $2.85 Billion for FDA for FY 17 Read More Advocacy at a Glance Guest User 2/19/16 Advocacy at a Glance Guest User 2/19/16 Alliance FY 17 “Ask” for FDA Funding Read More Analysis and Commentary Guest User 2/12/16 Analysis and Commentary Guest User 2/12/16 Of Smoke, Mirrors, and Advocacy Participation Read More Advocacy at a Glance Guest User 2/12/16 Advocacy at a Glance Guest User 2/12/16 President’s FY 17 Budget Request for FDA: Disappointing and Alarming and more Read More Uncategorized Guest User 2/10/16 Uncategorized Guest User 2/10/16 Alliance Alarmed and Disappointed by President's Budget Request for FY 17 Read More Analysis and Commentary Guest User 2/5/16 Analysis and Commentary Guest User 2/5/16 Hunting for the Wheat in the Chaff of Hyperbole Read More Advocacy at a Glance Guest User 2/5/16 Advocacy at a Glance Guest User 2/5/16 Obama-Proposed “Cancer Moonshot” Includes Monies for FDA Read More Analysis and Commentary Guest User 1/29/16 Analysis and Commentary Guest User 1/29/16 The Prompt Confirmation of a New Commissioner Read More Advocacy at a Glance Guest User 1/29/16 Advocacy at a Glance Guest User 1/29/16 Senator Murray Wants FDA at “Full Throttle;” Pushes Mandatory FDA Funding and more Read More Analysis and Commentary Guest User 1/23/16 Analysis and Commentary Guest User 1/23/16 Why Have We Watched "Cures" So Closely? Read More Advocacy at a Glance Guest User 1/23/16 Advocacy at a Glance Guest User 1/23/16 Federal Deficit Certain to Grow Over Next 10 Years and more Read More Analysis and Commentary Guest User 1/15/16 Analysis and Commentary Guest User 1/15/16 A Thank You ... and Now on to FY 17 Read More Advocacy at a Glance Guest User 1/15/16 Advocacy at a Glance Guest User 1/15/16 FY 17 Appropriations Process to Be Speeded Up and more Read More Analysis and Commentary Guest User 1/8/16 Analysis and Commentary Guest User 1/8/16 The Demonstration of Accountability to Multiple Stakeholders Read More Advocacy at a Glance Guest User 1/8/16 Advocacy at a Glance Guest User 1/8/16 FY17 Appropriations Process Begins Read More Newer Posts Older Posts
Advocacy at a Glance Guest User 3/12/16 Advocacy at a Glance Guest User 3/12/16 FDA to Apply Lean Management Tools to Handling of Combination Products and more Read More
Analysis and Commentary Guest User 3/4/16 Analysis and Commentary Guest User 3/4/16 Califf Debuts on Capitol Hill with Two Priorities Read More
Advocacy at a Glance Guest User 3/4/16 Advocacy at a Glance Guest User 3/4/16 National Biomedical Research Act Introduced Read More
Analysis and Commentary Guest User 2/27/16 Analysis and Commentary Guest User 2/27/16 "Everything is a high priority" for the FDA today Read More
Advocacy at a Glance Guest User 2/27/16 Advocacy at a Glance Guest User 2/27/16 Details on FDA’s Request for FY 17 FSMA Appropriations and more Read More
Analysis and Commentary Guest User 2/19/16 Analysis and Commentary Guest User 2/19/16 Alliance Seeks $2.85 Billion for FDA for FY 17 Read More
Advocacy at a Glance Guest User 2/19/16 Advocacy at a Glance Guest User 2/19/16 Alliance FY 17 “Ask” for FDA Funding Read More
Analysis and Commentary Guest User 2/12/16 Analysis and Commentary Guest User 2/12/16 Of Smoke, Mirrors, and Advocacy Participation Read More
Advocacy at a Glance Guest User 2/12/16 Advocacy at a Glance Guest User 2/12/16 President’s FY 17 Budget Request for FDA: Disappointing and Alarming and more Read More
Uncategorized Guest User 2/10/16 Uncategorized Guest User 2/10/16 Alliance Alarmed and Disappointed by President's Budget Request for FY 17 Read More
Analysis and Commentary Guest User 2/5/16 Analysis and Commentary Guest User 2/5/16 Hunting for the Wheat in the Chaff of Hyperbole Read More
Advocacy at a Glance Guest User 2/5/16 Advocacy at a Glance Guest User 2/5/16 Obama-Proposed “Cancer Moonshot” Includes Monies for FDA Read More
Analysis and Commentary Guest User 1/29/16 Analysis and Commentary Guest User 1/29/16 The Prompt Confirmation of a New Commissioner Read More
Advocacy at a Glance Guest User 1/29/16 Advocacy at a Glance Guest User 1/29/16 Senator Murray Wants FDA at “Full Throttle;” Pushes Mandatory FDA Funding and more Read More
Analysis and Commentary Guest User 1/23/16 Analysis and Commentary Guest User 1/23/16 Why Have We Watched "Cures" So Closely? Read More
Advocacy at a Glance Guest User 1/23/16 Advocacy at a Glance Guest User 1/23/16 Federal Deficit Certain to Grow Over Next 10 Years and more Read More
Analysis and Commentary Guest User 1/15/16 Analysis and Commentary Guest User 1/15/16 A Thank You ... and Now on to FY 17 Read More
Advocacy at a Glance Guest User 1/15/16 Advocacy at a Glance Guest User 1/15/16 FY 17 Appropriations Process to Be Speeded Up and more Read More
Analysis and Commentary Guest User 1/8/16 Analysis and Commentary Guest User 1/8/16 The Demonstration of Accountability to Multiple Stakeholders Read More
Advocacy at a Glance Guest User 1/8/16 Advocacy at a Glance Guest User 1/8/16 FY17 Appropriations Process Begins Read More
